Close menu




March 3rd, 2021 | 05:50 CET

ProSiebenSat.1 Media, Aspermont, Alibaba: Digital media as a multiplier opportunity

  • Investments
Photo credits: pixabay.com

When investors think of the media industry, they often still have stories of declining circulation and dwindling audiences in the back of their minds. But they often forget that media companies have long since made a virtue of necessity and gone digital. It is precisely when traditional media companies' quality meets modern digital groups' possibilities that great opportunities arise for investors. We present three shares.

time to read: 2 minutes | Author: Nico Popp
ISIN: DE000PSM7770 , AU000000ASP3 , US01609W1027

Table of contents:


    ProSiebenSat.1 Media: More dating than TV

    The ProSiebenSat.1 Media share is an old acquaintance on the German trading floor. But while the stock stood primarily for two TV stations for many years, today the Company is more than that. ProSiebenSat.1 is a big player in online dating. JP Morgan analysts recently emphasized that ProSiebenSat.1's stake in ParshipMeet is worth more than previously thought. The analysts, therefore, describe the share as a "key pick" among European media stocks.

    Over the past year, the share price performance shows a steep upward trend and a return of more than 60%. Given this development, the question arises to what extent ProSiebenSat.1 stock can still be moderately valued. Currently, the market capitalization is just over EUR 3 billion. As earnings are expected to be higher in 2021, this also justifies a rising share price. However, the ProSiebenSat.1 share is no longer an insider tip.

    Aspermont: Major investors get on board

    The shares of the Australian media Group Aspermont, on the other hand, are much less well known - although the Company stands for renowned titles such as Mining Journal and Mining Magazine, both of which have been published without interruption for more than a hundred years. There are numerous other brands and services that Aspermont offers its customers. After challenging years, the Company has gone digital and now distributes 95% of its content on digital channels. The customers: Companies from around the world working in, or supplying to, the mining, energy, and agricultural sectors.

    Over the years, Aspermont has built up a network of over seven million contacts, all of which are decision-makers in the respective companies. Aspermont intends to use these contacts to sell additional services in the future. Up to now, Aspermont has been quite accommodating toward business customers and has even turned a blind eye when several employees used access at the same time. In the long term, this could prove to be a smart move and help to bring new products to customers or adapt established subscriptions to actual usage. Aspermont sees potential in online commerce platforms, blockchain and e-learning.

    Recently, the Company announced a capital increase at AUD 0.03 per share, for which trading on its home exchange in Australia was suspended for one day. The move is backed by a single institutional investor from Germany and flushes AUD 3 million into the Company's coffers. In total, the Company now has more than AUD 7 million in its coffers and plans to invest the funds in further growth. Institutional investor confidence should help further publicize the investment story around Aspermont and stabilize the share price at current levels. With a market capitalization of less than EUR 30 million, the stock is a real insider's tip.

    Alibaba remains uncertain

    In contrast, the Alibaba share is well-known around the globe. The Company is considered Asia's Amazon and is just as broadly positioned. A few months ago, the canceled IPO of the fintech subsidiary Ant Group caused a furor. What was planned to be the largest IPO ever had to be postponed under pressure from Beijing. The appearance of Alibaba founder Jack Ma was seemingly too self-confident for the powers that be in Beijing. In the meantime, Ant Group has restructured itself and wants to manage the IPO in a second attempt. The hiccups have not been good for the parent Company Alibaba's share price: over one year, the investment return is only 6.3%. The share remains a hot topic.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read